Literature DB >> 22177147

Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes.

R P Meijer1, R P P Meijer, C J M Nunnink, A E Wassenaar, A Bex, H G van der Poel, B W van Rhijn, W Meinhardt, S Horenblas.   

Abstract

PURPOSE: We compared the nodal yield after histopathological examination of extended bilateral pelvic lymph node dissection specimens for bladder cancer at 2 hospitals. Surgery at each hospital was done by the same 4 staff urologists using a standardized extended bilateral pelvic lymph node dissection template.
MATERIALS AND METHODS: All consecutive patients with bladder cancer who underwent extended bilateral pelvic lymph node dissection from January 1, 2007 to December 31, 2009 were included in this study. Specimens were sent for pathological evaluation in a minimum of 2 packages per side. At the 2 pathology departments specimens were processed according to institutional protocols.
RESULTS: A total of 174 patients with a mean age of 62.7 years were included in analysis. At hospital 1 a mean of 16 lymph nodes were found after dissection vs a mean of 28 reported at hospital 2 (p <0.001). No significant differences were found in the number of tumor positive lymph nodes (p = 0.65). Mean lymph node density at hospitals 1 and 2 was 9.3% and 3.9%, respectively (p = 0.056).
CONCLUSIONS: Despite equal anatomical clearance by the same experienced surgeons we report a statistically significant difference between 2 pathology departments where the number of lymph nodes was evaluated after extended bilateral pelvic lymph node dissection for bladder cancer. Unless standardized methods are agreed on by pathologists, the number of reported lymph nodes as an indicator of surgical quality and lymph node density as a prognostic factor should be used cautiously.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22177147     DOI: 10.1016/j.juro.2011.10.029

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.

Authors:  H Abdi; F Pourmalek; M E Gleave; A I So; P C Black
Journal:  World J Urol       Date:  2015-11-30       Impact factor: 4.226

Review 2.  Extent of pelvic lymph node dissection during radical cystectomy: is bigger better?

Authors:  Debasish Sundi; Robert S Svatek; Matthew E Nielsen; Mark P Schoenberg; Trinity J Bivalacqua
Journal:  Rev Urol       Date:  2014

Review 3.  The role of extensive lymphadenectomy in upper tract malignant disease.

Authors:  Travis Pagliara; Andrew Nguyen; Badrinath Konety
Journal:  Curr Urol Rep       Date:  2014-11       Impact factor: 3.092

4.  Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival.

Authors:  L S Mertens; R P Meijer; E van Werkhoven; A Bex; H G van der Poel; B W van Rhijn; W Meinhardt; S Horenblas
Journal:  World J Urol       Date:  2012-08-09       Impact factor: 4.226

5.  Extended pelvic lymph node dissection at the time of robot-assisted radical prostatectomy: Impact of surgical volume on efficacy and complications in a single-surgeon series.

Authors:  Giovanni Battista Di Pierro; Pietro Grande; Johann Gregory Wirth; Hansjörg Danuser; Agostino Mattei
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

6.  Validation of the prognostic value of lymph node ratio in patients with penile squamous cell carcinoma: a population-based study.

Authors:  Yao Zhu; Cheng-Yuan Gu; Ding-Wei Ye
Journal:  Int Urol Nephrol       Date:  2013-07-23       Impact factor: 2.370

7.  Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.

Authors:  M Gierth; H M Fritsche; H Buchner; M May; A Aziz; W Otto; C Bolenz; L Trojan; E Hermann; A Tiemann; S C Müller; J Ellinger; S Brookman-May; C G Stief; D Tilki; P Nuhn; T Höfner; M Hohenfellner; A Haferkamp; J Roigas; M Zacharias; W F Wieland; H Riedmiller; S Denzinger; P J Bastian; M Burger
Journal:  World J Urol       Date:  2013-06-05       Impact factor: 4.226

8.  Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.

Authors:  Eu Chang Hwang; Niranjan J Sathianathen; Mari Imamura; Gretchen M Kuntz; Michael C Risk; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2019-05-14

9.  Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution.

Authors:  Roland Seiler; George N Thalmann; Pascal Zehnder
Journal:  Res Rep Urol       Date:  2013-08-12

10.  Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer.

Authors:  Allen S Ho; Sungjin Kim; Mourad Tighiouart; Cynthia Gudino; Alain Mita; Kevin S Scher; Anna Laury; Ravi Prasad; Stephen L Shiao; Jennifer E Van Eyk; Zachary S Zumsteg
Journal:  J Clin Oncol       Date:  2017-09-07       Impact factor: 50.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.